Zeis Thomas, Graumann Ursula, Reynolds Richard, Schaeren-Wiemers Nicole
Neurobiology, Department of Research, University Hospital Basel, Pharmacenter, Basel, Switzerland.
Brain. 2008 Jan;131(Pt 1):288-303. doi: 10.1093/brain/awm291. Epub 2007 Dec 4.
Multiple sclerosis is a chronic inflammatory disease of the CNS. Although progressive axonal injury and diffuse inflammatory damage has been shown in the chronic phase of the disease, little is known about the molecular mechanisms underlying these pathological processes. In order to identify these mechanisms, we have studied the gene expression profile in non-lesion containing tissue, the so-called normal-appearing white matter (NAWM). We performed differential gene expression analysis and quantitative RT-PCR on subcortical white matter from 11 multiple sclerosis and 8 control cases. Differentially expressed genes were further analysed in detail by in situ hybridization and immunofluorescence studies. We show that genes known to be involved in anti-inflammatory and protective mechanisms such as STAT6, JAK1, IL-4R, IL-10, Chromogranin C and Hif-1alpha are consistently upregulated in the multiple sclerosis NAWM. On the other hand, genes involved in pro-inflammatory mechanisms, such as STAT4, IL-1beta and MCSF, were also upregulated but less regularly. Immunofluorescence colocalization analysis revealed expression of STAT6, JAK1, IL-4R and IL-13R mainly in oligodendrocytes, whereas STAT4 expression was detected predominantly in microglia. In line with these data, in situ hybridization analysis showed an increased expression in multiple sclerosis NAWM of HIF-1alpha in oligodendrocytes and HLA-DRalpha in microglia cells. The consistency of the expression levels of STAT6, JAK1, JAK3 and IL-4R between the multiple sclerosis cases suggests an overall activation of the STAT6-signalling pathway in oligodendrocytes, whereas the expression of STAT4 and HLA-DRalpha indicates the activation of pro-inflammatory pathways in microglia. The upregulation of genes involved in anti-inflammatory mechanisms driven by oligodendrocytes may protect the CNS environment and thus limit lesion formation, whereas the activation of pro-inflammatory mechanisms in microglia may favour disease progression. Altogether, our data suggests an endogenous inflammatory reaction throughout the whole white matter of multiple sclerosis brain, in which oligodendrocytes actively participate. This reaction might further influence and to some extent facilitate lesion formation.
多发性硬化症是一种中枢神经系统的慢性炎症性疾病。尽管在该疾病的慢性期已显示出进行性轴突损伤和弥漫性炎症损伤,但对于这些病理过程背后的分子机制知之甚少。为了确定这些机制,我们研究了不含病变组织(即所谓的正常外观白质,NAWM)中的基因表达谱。我们对11例多发性硬化症患者和8例对照者的皮质下白质进行了差异基因表达分析和定量逆转录聚合酶链反应。通过原位杂交和免疫荧光研究对差异表达基因进行了进一步详细分析。我们发现,已知参与抗炎和保护机制的基因,如信号转导子和转录激活子6(STAT6)、Janus激酶1(JAK1)、白细胞介素4受体(IL-4R)、白细胞介素10(IL-10)、嗜铬粒蛋白C和低氧诱导因子-1α(Hif-1α),在多发性硬化症的NAWM中持续上调。另一方面,参与促炎机制的基因,如信号转导子和转录激活子4(STAT4)、白细胞介素1β(IL-1β)和巨噬细胞集落刺激因子(MCSF),也有上调,但规律性较差。免疫荧光共定位分析显示,STAT6、JAK1、IL-4R和白细胞介素13受体(IL-13R)主要在少突胶质细胞中表达,而STAT4表达主要在小胶质细胞中检测到。与这些数据一致,原位杂交分析显示,多发性硬化症NAWM中少突胶质细胞中的HIF-1α和小胶质细胞中的人类白细胞抗原DRα(HLA-DRα)表达增加。多发性硬化症病例之间STAT6、JAK1、JAK3和IL-4R表达水平的一致性表明少突胶质细胞中STAT6信号通路的整体激活,而STAT4和HLA-DRα的表达表明小胶质细胞中促炎途径的激活。少突胶质细胞驱动的抗炎机制相关基因的上调可能保护中枢神经系统环境,从而限制病变形成,而小胶质细胞中促炎机制的激活可能有利于疾病进展。总之,我们的数据表明,在多发性硬化症脑的整个白质中存在内源性炎症反应,少突胶质细胞积极参与其中。这种反应可能会进一步影响并在一定程度上促进病变形成。